公开(公告)号：US20220002336A1

公开(公告)日：2022-01-06

申请号：US17292963

申请日：2019-11-11

申请人： MITSUBISHI TANABE PHARMA CORPORATION ,  OSAKA UNIVERSITY

发明人： Hiroaki SAWAMOTO ,  Shinji KUMAGAI ,  Hiroyuki FURUKAWA ,  Tomo ARAKI ,  Masayuki UTSUGI ,  Satoshi OBIKA

IPC分类号： C07H19/20 ,  C07H19/10 ,  C07H21/04

摘要： The present invention provides a novel bridged artificial nucleic acid and an oligomer containing the same as a monomer. The present invention provides specifically a compound represented by general formula (I) (wherein each symbol is the same as defined in the specification) or salts thereof; as well as an oligonucleotide compound represented by general formula (I′) (wherein each symbol is the same as defined in the specification) or salts thereof.